Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka to discuss the potential impact of CRISPR and iPS cells over the coming decade and hear from the two world-class scientists about how they plan to shape the enormous opportunities that lie ahead.

Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for his discovery of induced pluripotent stem cells (iPS cells). And last year, Doudna received the Nobel Prize in Chemistry for her co-discovery of the CRISPR-Cas9 gene-editing technology. Arguably the two most impactful advances of this century, the discoveries by these Gladstone investigators are now accelerating our understanding and treatment of human disease at an unprecedented pace.

Featured Experts

Support Discovery Science

Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.

Donate Now

Up Next


CRISPR-Powered ‘Cancer Shredding’ Technique Opens New Possibility for Treating Most Common and Deadly Brain Cancer

Jennifer Doudna speaking to I-Li Tan in the lab at Gladstone
Article November 27, 2023

CRISPR-Powered ‘Cancer Shredding’ Technique Opens New Possibility for Treating Most Common and Deadly Brain Cancer

Gladstone Institutes researchers leveraged CRISPR to target and rapidly destroy glioblastoma cells in an approach that could carry over to other highly mutated cancers

News Release Research (Publication) Cancer Doudna Lab CRISPR/Gene Editing

More News